This Autumn, we have something new to bring you; a supplement covering the latest developments in the urological management of male fertility. Entitled Fertility Focus, the supplement gathers the views and analysis of a selection of the top experts in the field. The digital edition is available below – print copies have been mailed with each copy of our Sep/Oct issue, and additional ones are available upon request. We hope it makes fascinating reading!



  • Update on the management of varicoceles in infertile men
    - Musaab Yassin, Michael Ager, Tharu Tharakan, Suks Minhas
  • Correctable causes of obstructive azoospermia
    - Raveen Kaur Sandher, Majid Shabbir
  • Vasectomy reversal – a contemporary review of UK practice
    - Abdullah Almitwalli, Mark Johnson, David Ralph
  • An update on male hypogonadism and fertility
    - Patrick Gordon, Ian Eardley
  • Adolescent and childhood fertility preservation
    - Shafiullah Wardak, Philippa Sangster
  • DNA fragmentation: a guide for clinicians
    - Jonathan Ramsay


Supplement Co-ordinating Editor Jonathan Ramsay:

“These authoritative reviews explore what urologists are able to do for sub-fertile men – it is about enhancing and preserving male fertility. There are many reasons to be involved; we may improve natural conception rates, we may facilitate a cycle of intracytoplasmic sperm injection (ICSI) by raising a ‘cryptospermia’ to an ‘oligospermia’, and we may improve ICSI outcomes. However, we will also help our patients to understand, and maybe to accept more easily, a difficult diagnosis.”



Professor Ralf Henkel (Imperial College London/University of the Western Cape) and Professor Ashok Agarwal (Cleveland Clinic) are conducting an international online survey on the prescription of antioxidants for infertile patients, and have requested that we invite you to participate in this study.

There is conflicting data about the efficacy and utility of antioxidants (nutraceuticals) in the treatment of male infertility. Due to diametrically opposite findings and conclusions in recent studies, we have created a survey regarding the use of antioxidants for the treatment of male infertility. The main objective of this survey is to better understand the use of antioxidants and practice patterns of reproductive professionals involved in the care of patients with male infertility - especially those who are actively considering antioxidant supplement therapy for some of their patients 

- Professor Ralf Henkel


This Online Survey was reviewed and approved by Cleveland Clinic's Ethics Committee.
It will take around 10 minutes, and is composed of 5 sections:

  1. Demographic data
  2. Clinical practice
  3. Oxidative stress testing
  4. Antioxidant therapy
  5. Contact details (optional)

Please use the secure link below to participate in this important online survey of physician practice patterns.

Link to access the survey.


We’d like to thank LogixX Fertility for sponsoring the Fertility Focus project and enabling this supplement to happen. LogixX Fertility specialise in commercialising innovative Fertility and Sexual Health Products, and have recently expanded their portfolio to bring new diagnostics and therapies to patients, new treatment approaches to healthcare professionals, and better health outcomes for patients trying to conceive.

LogixX Fertility supports a number of national and international research-based projects with some world-leading experts in the area of reproduction to enhance knowledge, education and ultimately the options available to patients. You can find out more about LogixX at

The LogixX urology range currently consists of the following key elements;


LensHooke™ X1 PRO Semen Quality Analyzer

LensHooke™ X1 PRO is an easy-to-use, optical device which provides direct and calculated measurements for:

  • Sperm concentration (106 per ml)
  • Total motility (PR+NP, %)
  • Progressive motility (%)
  • Non-Progressive motility (%)
  • Immotility (%)
  • Other parameters from CASA assessment (ex: VSL, VAP, STR, ALH.... etc.)
  • Sperm morphology (normal forms, %)



MiOXSYS™ is a rapid advanced diagnostic semen analysis test that accurately measures oxidative-reductive (OR) stress in human semen.

MiOXSYS’s oxidation-reduction potential- sORP represents an integrated measure of all oxidants & reductants, making it a more clinically meaningful measure when diagnosing idiopathic cases associated with high levels of oxidative stress.

CLICK HERE to view Diagnostic and Therapeutic Scheme for Seminal Oxidative Stress 


Proxeed Plus

Proxeed Plus is a high-quality fertility supplement specifically designed to support healthy sperm development and maximise a man’s chances of fathering a child.

The ingredients have been shown to play a critical role in the development of sperm, and in assuring its quality and performance, by providing energy to the developing sperm cell, while simultaneously protecting it from oxidative stress.


ZyMot™ Microfluid Sperm Separation Device

ZyMot™ Microfluid Sperm Separation Device has been designed to efficiently isolate the healthiest, rapidly progressive sperm for use in the treatment of infertile couples by intrauterine insemination (IUI), in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) procedures to help achieve the best possible outcomes for use in ART (assisted reproductive techniques).

Visit for more details.